Am J Psychiatry. 1992 May;149(5):686-8.

Low cerebellar metabolism in medicated patients with chronic schizophrenia.

Volkow ND, Levy A, Brodie JD, Wolf AP, Cancro R, Van Gelder P, Henn F.

Source

Medical Department, Brookhaven National Laboratory, Upton, NY 11973.

Abstract

Because of the frequent association of cerebellar structural defects with schizophrenia, the authors reanalyzed the metabolic brain images of patients with chronic schizophrenia to assess if they had abnormalities in cerebellar metabolism. They used carbon-11-2-deoxyglucose and positron emission tomography to study 18 medicated patients with chronic schizophrenia and 12 normal comparison subjects. Patients with schizophrenia showed significantly lower absolute and relative metabolism in the cerebellum than normal subjects.

PMID:: 1575261; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, U.S. Gov't, Non-P.H.S.

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

COS Scholar Universe

Medical

Schizophrenia - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia. [Am J Psychiatry. 1987]
Phenomenological correlates of metabolic activity in 18 patients with chronic schizophrenia.
Volkow ND, Wolf AP, Van Gelder P, Brodie JD, Overall JE, Cancro R, Gomez-Mont F. Am J Psychiatry. 1987 Feb; 144(2):151-8.
Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. [Am J Psychiatry. 1985]
Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography.
Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, Gomez-Mont F, Cancro R. Am J Psychiatry. 1985 May; 142(5):564-71.
Low frontal glucose utilization in chronic schizophrenia: a replication study. [Am J Psychiatry. 1988]
Low frontal glucose utilization in chronic schizophrenia: a replication study.
Wolkin A, Angrist B, Wolf A, Brodie JD, Wolkin B, Jaeger J, Cancro R, Rotrosen J. Am J Psychiatry. 1988 Feb; 145(2):251-3.
Review [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography]. [Acta Psychiatr Belg. 1991]
Review [Cerebral glucose metabolism in schizophrenia. Studies using positron-emission tomography].
M'Rabet N, Lotstra F, Goldman S, Delvenne V, Mendlewicz J. Acta Psychiatr Belg. 1991; 91(6):311-26.
Review Positron emission tomography imaging of regional cerebral glucose metabolism. [Semin Nucl Med. 1986]
Review Positron emission tomography imaging of regional cerebral glucose metabolism.
Alavi A, Dann R, Chawluk J, Alavi J, Kushner M, Reivich M. Semin Nucl Med. 1986 Jan; 16(1):2-34.

See reviews... See all...

Cited by 3 PubMed Central articles

Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate. [Eur J Neurosci. 2010]
Dopamine D4 receptors modulate brain metabolic activity in the prefrontal cortex and cerebellum at rest and in response to methylphenidate.
Michaelides M, Pascau J, Gispert JD, Delis F, Grandy DK, Wang GJ, Desco M, Rubinstein M, Volkow ND, Thanos PK. Eur J Neurosci. 2010 Aug; 32(4):668-76. Epub 2010 Jul 16.
Review The role of the cerebellum in schizophrenia. [Biol Psychiatry. 2008]
Review The role of the cerebellum in schizophrenia.
Andreasen NC, Pierson R. Biol Psychiatry. 2008 Jul 15; 64(2):81-8. Epub 2008 Apr 8.
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia. [BMC Psychiatry. 2005]
Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H, Stensland M, Zhao Z, Kinon BJ. BMC Psychiatry. 2005 Jan 13; 5:3. Epub 2005 Jan 13.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Low cerebellar metabolism in medicated patients with chronic schizophrenia.
Low cerebellar metabolism in medicated patients with chronic schizophrenia.
Am J Psychiatry. 1992 May ;149(5):686-8.

PubMed
Molecular mechanisms that set the stage for DC-T cell engagement.
Molecular mechanisms that set the stage for DC-T cell engagement.
Immunol Lett. 2005 Mar 15 ;97(2):199-208. Epub 2004 Dec 2 .

PubMed
Oculomotor performance in obsessive-compulsive disorder.
Oculomotor performance in obsessive-compulsive disorder.
Am J Psychiatry. 1992 May ;149(5):641-6.

PubMed
The 21st century health challenge of slums and cities.
The 21st century health challenge of slums and cities.
Lancet. 2005 Mar 5-11 ;365(9462):901-3.

PubMed
4 million neonatal deaths: when? Where? Why?
4 million neonatal deaths: when? Where? Why?
Lancet. 2005 Mar 5-11 ;365(9462):891-900.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: